VVOS - Vivos Therapeutics, Inc. -  [ ]

Ticker Details
Vivos Therapeutics, Inc.
IPO Date: July 7, 2020
Sector: Healthcare
Industry: Medical Devices
Market Cap: $18.61M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.18 | 5.00%
Avg Daily Range (30 D): $0.07 | 3.88%
Avg Daily Range (90 D): $0.08 | 3.62%
Institutional Daily Volume
Avg Daily Volume: .32M
Avg Daily Volume (30 D): .12M
Avg Daily Volume (90 D): .14M
Trade Size
Avg Trade Size (Sh.): 91
Avg Trade Size (Sh.) (30 D): 167
Avg Trade Size (Sh.) (90 D): 197
Institutional Trades
Total Institutional Trades: 25
Avg Institutional Trade: $.96M
Avg Institutional Trade (30 D): $.65M
Avg Institutional Trade (90 D): $.65M
Avg Institutional Trade Volume: .03M
Avg Institutional Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $1.05M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $.84M
Avg Closing Volume: 12.46K
 
News
Jan 21, 2026 @ 6:00 PM
Global Sleep Apnea Devices Market is Expected to C...
Source: Delveinsight
Jan 20, 2026 @ 10:31 PM
Vivos Therapeutics Announces Closing of Exercise o...
Source: Na
Dec 15, 2025 @ 10:30 PM
Vivos Therapeutics to Participate in Online Firesi...
Source: Vivos Therapeutics, Inc.
Aug 20, 2025 @ 8:24 PM
Vivos Reports 7% Sales Drop
Source: Jesterai
Jun 27, 2024 @ 11:30 AM
Vivos Therapeutics Announces Positive Results From...
Source: Vivos Therapeutics, Inc
Financials
  TTM Q3 2025 Q2 2025
Basic EPS $-1.77 $-.49 $-.55
Diluted EPS $-1.77 $-.49 $-.55
Revenue $17.32M $6.78M $3.82M
Gross Profit $9.65M $3.94M $2.11M
Net Income / Loss $-17.1M $-5.4M $-5.01M
Operating Income / Loss $-16.32M $-4.73M $-4.87M
Cost of Revenue $7.66M $2.85M $1.71M
Net Cash Flow $-3.22M $-1.32M $-1.86M
PE Ratio    
Splits
Oct 27, 2023 1:25